Market Access Lead, DACH — Pricing & Payer Strategy

Sobi; Zug; Sur place; CHF 120 000 - 180 000; Plein temps

Avantages offerts par ce poste

Competitive compensation

Work-life balance

Collaborative environment

Professional growth

Diversity and Inclusion

Impactful work

Résumé du poste

Sobi is seeking a Market Access professional to shape pricing and reimbursement strategies for Haemophilia, Haematology and Immunology products in the DACH region. The role involves cross-functional collaboration with finance, sales and patient access to optimize market access outcomes.

You will work with authorities, payers and physicians to support sustainable access to innovative therapies while contributing to HEOR initiatives and real-world evidence plans.

Qualifications

• Bachelor’s or Master’s degree in Life Sciences, Pharmacy, Healthcare, Economics, Public Health, or related field.
• Recent graduates are welcome to apply.
• Academic experience in market access, health economics, pricing & reimbursement, or healthcare policy is an advantage.

Responsabilités

• Identify pricing and positioning opportunities for Haemophilia, Haematology and Immunology products.
• Collaborate with finance, sales and patient access to manage pricing and reimbursement offers.
• Develop pricing and contracting strategies with sick funds and physician associations.
• Produce and analyze contract/payer specific reports.
• Engage with national and regional authorities on pricing and reimbursement requirements.

Connaissances

Market access knowledge

Pricing & reimbursement

Healthcare policy

Formation

Bachelor’s or Master’s degree

Recent graduates welcome

Description du poste

Sobi is seeking a Market Access professional to shape pricing and reimbursement strategies for Haemophilia, Haematology and Immunology products in the DACH region. The role involves cross-functional collaboration with finance, sales and patient access to optimize market access outcomes.

You will work with authorities, payers and physicians to support sustainable access to innovative therapies while contributing to HEOR initiatives and real-world evidence plans.